Evidence map›Paper›PMID 41204398›Full record

ArticleBMC medicine2025

Protein intake and transitions between frailty states in middle-aged and older adults: a multi-state transition model in the UK Biobank.

Nuno Mendonça, Ana Maria Rodrigues, Ana Rita Henriques, Helena Canhão, Armando Raimundo, Carlos Celis-Morales

Abstract read
In one paragraph

Article in BMC medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nuno MendonçaEpiDoC Unit, CHRC, LA-REAL, NOVA Medical School, Universidade NOVA de Lisboa, Rua Do Instituto Bacteriológico, nº5, Lisbon, 1150-082, Portugal. nuno.mendonca@nms.unl.pt.
Ana Maria RodriguesEpiDoC Unit, CHRC, LA-REAL, NOVA Medical School, Universidade NOVA de Lisboa, Rua Do Instituto Bacteriológico, nº5, Lisbon, 1150-082, Portugal.
Ana Rita HenriquesEpiDoC Unit, CHRC, LA-REAL, NOVA Medical School, Universidade NOVA de Lisboa, Rua Do Instituto Bacteriológico, nº5, Lisbon, 1150-082, Portugal.
Helena CanhãoEpiDoC Unit, CHRC, LA-REAL, NOVA Medical School, Universidade NOVA de Lisboa, Rua Do Instituto Bacteriológico, nº5, Lisbon, 1150-082, Portugal.
Armando RaimundoCHRC, LA-REAL, Departamento de Desporto e Saúde, Escola de Saúde e Desenvolvimento Humano, Universidade de Évora, Évora, Portugal.
Carlos Celis-MoralesSchool of Cardiovascular and Metabolic Sciences, University of Glasgow, Glasgow, UK.

Funding

Comprehensive Health Research Center UIDB/04923/2020Fundação para a Ciência e Tecnologia 2021.00745.CEECIND
6 · The paper itself

Abstract

backgroundDietary protein may prevent or modulate the progression of frailty, by slowing down the decline of muscle mass, strength, and physical function with ageing. We aimed to examine the association between higher protein intake and transitions between frailty states.

methodsThe analytic sample included 27,128 participants aged 50 + from the UK Biobank cohort study. Physical frailty at baseline and follow-up was based on slow walking speed, unintentional weight loss, exhaustion, low physical activity, and weakness. Protein intake was assessed with web-based 24 h recalls on up to 5 occasions. The effect of protein intake on forward and backward transitions (and maintenance) between frailty states (non-frailty, pre-frailty, and frailty) and to death over a mean of 5 (max 16) years was examined with multi-state models.

resultsThere were 5646 transitions from non-frail to pre-frail, 4187 from pre-frail to non-frail, 552 from pre-frail to frail, and 311 from frail to pre-frail. Middle-aged and older participants with higher protein intake (increments of 0.1 g/kg bodyweight/day and protein categories of < 0.8 (ref), 0.8 to < 1.0, 1.0 to < 1.2, ≥ 1.2 g/kg bodyweight/day) were less likely to progress from pre-frailty to frailty, and appeared to be more likely to recover from pre-frailty to non-frailty, with evidence of a dose-dependent relationship. E.g. For participants with protein intake of 0.8 to < 1.0, 1.0 to < 1.2 and ≥ 1.2, hazard ratios (95%CI) for incident frailty were 0.80 (0.71-0.91), 0.72 (0.63-0.81) and 0.68 (0.60-0.78), respectively, compared to < 0.8 g/kg bodyweight/day. Higher protein intake had no effect on recovery from frailty to pre-frailty.

conclusionsHigher protein intake moderately reduced the risk for frailty incidence and may have increased the likelihood of recovery from pre-frailty in a dose-dependent manner in middle-aged and older adults. These findings may optimize strategies to prevent frailty in middle-aged and older adults and inform dietary protein guidelines in this population.

Indexed as

Dietary ProteinsFrail ElderlyFrailtyAgedAged, 80 and overBiological Specimen BanksCohort StudiesFemaleHumansMaleMiddle AgedUK BiobankUnited KingdomDietary ProteinsAgeingCohortFrailtyProteinTransitions

Identifiers

PMID41204398
PMCPMC12595627

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.